SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001787306-24-000029
Filing Date
2024-02-27
Accepted
2024-02-27 07:44:28
Documents
16
Period of Report
2024-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20240227.htm   iXBRL 8-K 27572
2 EX-99.1 pressreleaseex991q42023.htm EX-99.1 111089
6 a1a82.jpg GRAPHIC 25530
  Complete submission text file 0001787306-24-000029.txt   315647

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20240227.xsd EX-101.SCH 1889
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20240227_lab.xml EX-101.LAB 25156
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20240227_pre.xml EX-101.PRE 13038
17 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20240227_htm.xml XML 2864
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 24682018
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)